Obtaining Reliable RT‐qPCR Results in Molecular Diagnostics—MIQE Goals and Pitfalls for Transcriptional Biomarker Discovery

In this review, we discuss the development pipeline for transcriptional biomarkers in molecular diagnostics and stress the importance of a reliable gene transcript quantification strategy. Hence, a further focus is put on the MIQE guidelines and how to adapt them for biomarker discov-ery, from signature validation up to routine diagnostic applications. First, the advantages and pitfalls of the holistic RNA sequencing for biomarker development will be described to establish a candidate biomarker signature. Sequentially, the RT‐qPCR confirmation process will be discussed to validate the discovered biomarker signature. Examples for the successful application of RT‐qPCR as a fast and reproducible quantification method in routinemolecular diagnostics are provided. Based on the MIQE guidelines, the importance of “key steps” in RT‐qPCR is accurately described, e.g., reverse transcription, proper reference gene selection and, finally, the application of automated RT‐qPCR data analysis software. In conclusion, RT‐qPCR proves to be a valuable tool in the estab-lishment of a disease‐specific transcriptional biomarker signature and will have a great future in molecular diagnostics or personalized medicine.